FirstName_09e4eaa4-74f6-4f13 LastName_09e4eaa4-74f6-4f13

0000-0002-4555-6446

Career

Institution and position
18.05.2015–...    Protobios LLC, Post-Doc (1,00)
 
 
Education
10.02.2010–17.04.2015   

Qualifications

Field of research
FIELD OF RESEARCH: 1. Biosciences and Environment; 1.2. Microbiology; CERCS SPECIALTY: B230 Microbiology, bacteriology, virology, mycology
 
 
Additional information

Publications

Category
Year
Publication
 
1.1.
2016
1.1.
2016
1.1.
2015
1.1.
2014
1.1.
2012
1.1.
2012
1.1.
2011

FirstName_09e4eaa4-74f6-4f13 LastName_09e4eaa4-74f6-4f13

0000-0002-4555-6446

Teenistuskäik

Töökohad ja ametid
18.05.2015–...    Protobios OÜ, Järeldoktor (1,00)
 
 
Haridustee
10.02.2010–17.04.2015    PhD in Biosciences, University of Helsinki

Kvalifikatsioon

Teadustöö põhisuunad
VALDKOND: 1. Bio- ja keskkonnateadused; 1.2. Mikrobioloogia; CERCS ERIALA: B230 Mikrobioloogia, bakterioloogia, viroloogia, mükoloogia ; PÕHISUUND: molecular virology, molecular biology
 
 
Lisainfo
no additional information

Publikatsioonid

Klass
Aasta
Publikatsioon
 
1.1.
2016
1.1.
2016
1.1.
2015
1.1.
2014
1.1.
2012
1.1.
2012
1.1.
2011
  • Leitud 1 kirjet
ProgrammNumberNimiProjekti algusProjekti lõppVastutav täitjaAsutusRahastamine kokku
MUUEU612308Academic Industry R&D Opportunities for Picornaviruses01.10.201430.09.2019FirstName_722215 LastName_722215Protobios OÜ232 321,00 EUR
  • Leitud 7 kirjet
PublikatsioonKlassifikaatorFail
Söderholm, Sandra; Anastasina, Maria; Islam, Mohammad Majharul; Tynell, Janne; Poranen, Minna M; Bamford, Dennis H; Stenman, Jakob; Julkunen, Ilkka; Šaulienė, Ingrida; De Brabander, Jef K; Matikainen, Sampsa; Nyman, Tuula A; Saelens, Xavier; Kainov, Denis (2016). Immuno-modulating properties of saliphenylhalamide, SNS-032, obatoclax, and gemcitabine. Antiviral research, 126, 69−80, 10.1016/j.antiviral.2015.12.011.1.1.
Anastasina M, Le May N, Bugai A, Fu Y, Söderholm S, Gaelings L, Ohman T, Tynell J, Kyttänen S, Barboric M, Nyman TA, Matikainen S, Julkunen I, Butcher SJ, Egly JM, Kainov DE. (2016). Influenza virus NS1 protein binds cellular DNA to block transcription of antiviral genes. Biochimica et Biophysica Acta - Gene Regulatory Mechanisms, 1859 (11), 1440−1448.1.1.
Anastasina M, Schepens B, Söderholm S, Nyman TA, Matikainen S, Saksela K, Saelens X, Kainov DE. (2015). The C terminus of NS1 protein of influenza A/WSN/1933(H1N1) virus modulates antiviral responses in infected human macrophages and mice. Journal of General Virology, 96 (8), 2086−2091.1.1.
Anastasina M, Terenin I, Butcher SJ, Kainov DE. (2014). A technique to increase protein yield in a rabbit reticulocyte lysate translation system. Biotechniques, 56 (1), 36−39.1.1.
Müller KH, Kakkola L, Nagaraj AS, Cheltsov AV, Anastasina M, Kainov DE (2012). Emerging cellular targets for influenza antiviral agents. Trends in Pharmacological Sciences, 33 (2), 89−99.1.1.
Feng L, Lintula S, Ho TH, Anastasina M, Paju A, Haglund C, Stenman UH, Hotakainen K, Orpana A, Kainov D, Stenman J. (2012). Technique for strand-specific gene-expression analysis and monitoring of primer-independent cDNA synthesis in reverse transcription. Biotechniques, 52 (4), 263−270.1.1.
Kainov DE, Müller KH, Theisen LL, Anastasina M, Kaloinen M, Muller CP (2011). Differential effects of NS1 proteins of human pandemic H1N1/2009, avian highly pathogenic H5N1, and low pathogenic H5N2 influenza A viruses on cellular pre-mRNA polyadenylation and mRNA translation. Journal of Biological Chemistry, 286 (9), 7239−7247.1.1.